Profile data is unavailable for this security.
About the company
ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.
- Revenue in AUD (TTM)10.47m
- Net income in AUD-19.42m
- Incorporated1999
- Employees76.00
- LocationImpediMed LtdPinkenba, U 1 50 Parker CtBRISBANE 4008AustraliaAUS
- Phone+61 73860-3700
- Fax+61 73260-1225
- Websitehttps://www.impedimed.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imricor Medical Systems Inc | 923.72k | -33.95m | 89.12m | -- | -- | -- | -- | 96.48 | -0.2157 | -0.2157 | 0.0059 | -0.0778 | 0.0559 | 0.8749 | 2.38 | -- | -205.60 | -93.47 | -294.49 | -106.30 | -181.27 | -134.71 | -3,675.60 | -2,462.89 | 0.4944 | -3.64 | 15.92 | -- | -24.56 | -9.29 | -30.36 | -- | -10.82 | -- |
| SDI Ltd | 109.61m | 8.04m | 91.53m | 300.00 | 11.38 | 1.03 | 7.41 | 0.835 | 0.0676 | 0.0676 | 0.9221 | 0.7494 | 0.8449 | 1.69 | 6.22 | -- | 6.20 | 7.27 | 7.46 | 8.40 | 59.28 | 59.79 | 7.34 | 8.07 | 1.26 | 10.37 | 0.2318 | 51.85 | 13.35 | 7.67 | -3.09 | 4.50 | 52.58 | 5.39 |
| Genetic Signatures Ltd | 16.49m | -18.04m | 141.76m | -- | -- | 3.50 | -- | 8.59 | -0.1245 | -0.1245 | 0.1136 | 0.2172 | 0.3366 | 1.06 | 5.25 | -- | -36.81 | -7.14 | -40.19 | -7.82 | 40.66 | 57.68 | -109.38 | -13.74 | 5.95 | -18,040.00 | 0.0003 | -- | -38.11 | 33.44 | -558.77 | -- | 73.20 | -- |
| Cyclopharm Limited | 32.21m | -4.70m | 155.41m | 87.00 | -- | 4.81 | -- | 4.83 | -0.0508 | -0.0508 | 0.3476 | 0.3428 | 0.6748 | 1.11 | 4.13 | 370,173.10 | -9.85 | -12.60 | -11.92 | -14.94 | 68.15 | 70.20 | -14.60 | -25.47 | 2.32 | -18.40 | 0.1159 | -- | 11.22 | 15.50 | 28.90 | -- | -7.83 | -12.94 |
| Mach7 Technologies Ltd | 26.97m | -5.55m | 165.25m | 90.00 | -- | 3.04 | 76.35 | 6.13 | -0.0231 | -0.0231 | 0.1123 | 0.2256 | 0.3605 | -- | 3.21 | -- | -7.42 | -7.48 | -8.73 | -8.65 | 95.09 | 93.72 | -20.59 | -20.56 | -- | -2,605.17 | 0.0193 | -- | 10.97 | 28.30 | 74.85 | -- | 29.28 | -- |
| EMvision Medical Devices Ltd | 8.86m | -3.22m | 165.72m | -- | -- | 26.48 | -- | 18.70 | -0.0449 | -0.0449 | 0.1186 | 0.0733 | 0.7954 | -- | -- | -- | -28.95 | -67.20 | -45.25 | -79.38 | -- | -- | -36.40 | -175.99 | -- | -35.20 | 0.3424 | -- | 62.08 | 70.47 | 36.64 | -- | -- | -- |
| ImpediMed Ltd | 10.47m | -19.42m | 167.92m | 76.00 | -- | 3.29 | -- | 16.03 | -0.0102 | -0.0102 | 0.0055 | 0.0252 | 0.1961 | 1.32 | 4.41 | 137,802.60 | -36.37 | -52.27 | -40.94 | -62.34 | 86.95 | 80.64 | -185.47 | -264.76 | 6.85 | -- | 0.0244 | -- | 7.36 | 27.87 | -3.26 | -- | 37.83 | -- |
| Aroa Biosurgery Ltd | 60.22m | -7.58m | 170.38m | 261.00 | -- | 1.92 | -- | 2.83 | -0.0221 | -0.0221 | 0.1754 | 0.2585 | 0.5764 | 1.69 | 3.18 | 230,720.70 | -7.25 | -9.60 | -7.88 | -12.08 | 84.47 | 77.32 | -12.58 | -18.98 | 7.09 | -12.52 | 0.065 | -- | 59.68 | 41.68 | 95.28 | -- | 35.28 | -- |
| 4DMedical Ltd | 1.03m | -30.83m | 232.88m | -- | -- | 2.55 | -- | 227.15 | -0.0882 | -0.0882 | 0.0029 | 0.2332 | 0.0098 | 0.092 | 0.1585 | -- | -29.47 | -43.96 | -39.07 | -57.58 | 95.00 | 32.30 | -3,007.64 | -2,704.36 | 1.79 | -- | 0.0476 | -- | -31.84 | -1.86 | -27.92 | -- | 2.46 | -- |
| Paragon Care Ltd. | 317.39m | 10.31m | 247.11m | 0.00 | 24.23 | 0.9844 | 11.20 | 0.7786 | 0.0153 | 0.0124 | 0.4698 | 0.3759 | 0.6806 | 3.00 | 8.84 | -- | 2.54 | -1.78 | 3.32 | -2.33 | 40.92 | 39.55 | 3.73 | -2.58 | 0.7121 | 3.04 | 0.374 | -- | 29.55 | 21.27 | 111.05 | -1.54 | 26.29 | -17.29 |
| Holder | Shares | % Held |
|---|---|---|
| Paradice Investment Management Pty Ltd.as of 08 Mar 2024 | 174.19m | 8.61% |
| Australian Ethical Investments Ltd. (Investment Management)as of 08 Mar 2024 | 115.30m | 5.70% |
| DFA Australia Ltd.as of 31 Mar 2024 | 1.59m | 0.08% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 490.63k | 0.02% |
| North Star Asset Management, Inc.as of 31 Mar 2024 | 20.00k | 0.00% |
| Dimensional Fund Advisors Ltd.as of 09 May 2024 | 656.00 | 0.00% |
